Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breathe away the stress: biofeedback study targets heart health in minorities

NCT ID NCT07172152

Symptom relief Sponsor: Amelia Saul, PhD, CTRS, BCB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether a four-week heart rate variability biofeedback program—simple paced breathing exercises—could help young ethnic minority adults (ages 18-35) with a family history of heart disease manage stress and anxiety. Participants were randomly assigned to either the breathing group or a control group. Researchers measured changes in heart rate variability, anxiety levels, and stress responses to see if this low-cost, non-invasive approach could lower heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HRV biofeedback training (paced breathing exercises)
What this could lead to
If it works, this could point toward a simple, non-drug way to lower stress and heart disease risk in high-risk groups.
What could go wrong
This is a small, completed early-stage study with only 66 participants. Results may not apply to everyone, and benefits may be modest or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Sep 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults * Age 18 to 35 years * Cognitively intact to follow instructions * English-speaking * Family history of cardiovascular disease. Exclusion Criteria: * Cognitive impairments that inhibit understanding instruction * Current diagnosis of hypertension that is controlled with prescribed medication * Previously receiving biofeedback training * Having a severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes) * Being actively psychotic * Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data * Patients currently taking medications such as MAOIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) are excluded due to their potential to affect the HRV data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Cardiovascular disease risk reduction Chronic stress Emotional regulation Health disparities Hypertension prevention

Contacts and locations

Locations

  • Florida International University

    Miami, Florida, 33199, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.